{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:10:22Z","timestamp":1775650222401,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04747-6","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:53:56Z","timestamp":1772520836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study"],"prefix":"10.1186","volume":"24","author":[{"given":"Celestino","family":"Sardu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovica Vittoria","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando Carlo","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Nappo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ausilia","family":"Sellitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Carusone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nunzia","family":"D\u2019Onofrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Consiglia","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Cioffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Volpicelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"La Marca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natale","family":"Marrazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Landolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Abitabile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Balestrieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"4747_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cardfail.2013.05.001","volume":"19","author":"L Santini","year":"2013","unstructured":"Santini L, Capria A, Di Molfetta A, Mahfouz K, Panattoni G, Minni V, et al. Endothelial dysfunction is a marker of systemic response to the cardiac resynchronization therapy in heart failure. J Card Fail. 2013;19:419\u201325.","journal-title":"J Card Fail"},{"issue":"18","key":"4747_CR2","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895\u20131032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063.","journal-title":"Circulation"},{"issue":"1","key":"4747_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2015-000391","volume":"3","author":"DR Warriner","year":"2016","unstructured":"Warriner DR, Lawford P, Sheridan PJ. Measures of endothelial dysfunction predict response to cardiac resynchronisation therapy. Open Heart. 2016;3(1):e000391. https:\/\/doi.org\/10.1136\/openhrt-2015-000391.","journal-title":"Open Heart"},{"issue":"2","key":"4747_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021510","volume":"24","author":"C Sardu","year":"2023","unstructured":"Sardu C, Santulli G, Savarese G, Trotta MC, Sacra C, Santamaria M, et al. Endothelial dysfunction drives CRTd outcome at 1-year follow-up: a novel role as biomarker for miR-130a-5p. Int J Mol Sci. 2023;24(2):1510. https:\/\/doi.org\/10.3390\/ijms24021510.","journal-title":"Int J Mol Sci"},{"issue":"35","key":"4747_CR5","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","volume":"42","author":"M Glikson","year":"2021","unstructured":"Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42(35):3427\u2013520. https:\/\/doi.org\/10.1093\/eurheartj\/ehab364.","journal-title":"Eur Heart J"},{"issue":"20","key":"4747_CR6","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","volume":"382","author":"PW Armstrong","year":"2020","unstructured":"Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, et al. Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med. 2020;382(20):1883\u201393. https:\/\/doi.org\/10.1056\/NEJMoa1915928.","journal-title":"N Engl J Med"},{"key":"4747_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01030","volume":"9","author":"C Sardu","year":"2018","unstructured":"Sardu C, Pieretti G, D\u2019Onofrio N, Ciccarelli F, Paolisso P, Passavanti MB, et al. Inflammatory cytokines and SIRT1 levels in subcutaneous abdominal fat: relationship with cardiac performance in overweight pre-diabetics patients. Front Physiol. 2018;9:1030. https:\/\/doi.org\/10.3389\/fphys.2018.01030.","journal-title":"Front Physiol"},{"issue":"1","key":"4747_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-018-0778-9","volume":"17","author":"C Sardu","year":"2018","unstructured":"Sardu C, Paolisso P, Sacra C, Santamaria M, de Lucia C, Ruocco A, et al. Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate. Cardiovasc Diabetol. 2018;17(1):137. https:\/\/doi.org\/10.1186\/s12933-018-0778-9.","journal-title":"Cardiovasc Diabetol"},{"key":"4747_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00758","volume":"9","author":"C Sardu","year":"2018","unstructured":"Sardu C, Marfella R, Santamaria M, Papini S, Parisi Q, Sacra C, et al. Stretch, injury and inflammation markers evaluation to predict clinical outcomes after implantable cardioverter defibrillator therapy in heart failure patients with metabolic syndrome. Front Physiol. 2018;9:758. https:\/\/doi.org\/10.3389\/fphys.2018.00758.","journal-title":"Front Physiol"},{"key":"4747_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014506","volume":"6","author":"EA Jankowska","year":"2011","unstructured":"Jankowska EA, Filippatos GS, von Haehling S, Papassotiriou J, Morgenthaler NG, Cicoira M, et al. Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1. PLoS One. 2011;6:e14506.","journal-title":"PLoS One"},{"issue":"2","key":"4747_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257\u201365. https:\/\/doi.org\/10.1016\/s0735-1097(01)01746-6.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"4747_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102471","volume":"10","author":"F Vannuccini","year":"2022","unstructured":"Vannuccini F, Campora A, Barilli M, Palazzuoli A. Vericiguat in heart failure: characteristics, scientific evidence and potential clinical applications. Biomedicines. 2022;10(10):2471. https:\/\/doi.org\/10.3390\/biomedicines10102471.","journal-title":"Biomedicines"},{"issue":"6","key":"4747_CR13","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.cardfail.2021.02.008","volume":"27","author":"P Martens","year":"2021","unstructured":"Martens P, Dupont M, Vermeersch P, Dauw J, Nijst P, Bito V, et al. Impact of cardiac resynchronization therapy on global and cardiac metabolism and cardiac mitochondrial function. J Card Fail. 2021;27(6):706\u201315. https:\/\/doi.org\/10.1016\/j.cardfail.2021.02.008.","journal-title":"J Card Fail"},{"key":"4747_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121929","volume":"328","author":"P Jungtanasomboon","year":"2023","unstructured":"Jungtanasomboon P, Nussaro S, Winwan H, Suebthawinkul P, Boonpala P, Dong VNK, et al. Vericiguat preserved cardiac function and mitochondrial quality in a rat model of mitral regurgitation. Life Sci. 2023;328:121929. https:\/\/doi.org\/10.1016\/j.lfs.2023.121929.","journal-title":"Life Sci"},{"issue":"2","key":"4747_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10741-012-9323-1","volume":"18","author":"M Gheorghiade","year":"2013","unstructured":"Gheorghiade M, Marti CN, Sabbah HN, Roessig L, Greene SJ, B\u00f6hm M, et al. Soluble guanylate cyclase: a potential therapeutic target for heart failure. Heart Fail Rev. 2013;18(2):123\u201334. https:\/\/doi.org\/10.1007\/s10741-012-9323-1.","journal-title":"Heart Fail Rev"},{"issue":"22","key":"4747_CR16","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1093\/eurheartj\/ehq396","volume":"31","author":"T Munzel","year":"2010","unstructured":"Munzel T, Gori T, Bruno RM, Taddei S. Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J. 2010;31(22):2741\u20138.","journal-title":"Eur Heart J"},{"issue":"14","key":"4747_CR17","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1080\/14656566.2021.1937121","volume":"22","author":"JS Hulot","year":"2021","unstructured":"Hulot JS, Trochu JN, Donal E, Galinier M, Logeart D, De Groote P, et al. Vericiguat for the treatment of heart failure: mechanism of action and pharmacological properties compared with other emerging therapeutic options. Expert Opin Pharmacother. 2021;22(14):1847\u201355. https:\/\/doi.org\/10.1080\/14656566.2021.1937121.","journal-title":"Expert Opin Pharmacother"},{"issue":"21","key":"4747_CR18","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.2015.15734","volume":"314","author":"M Gheorghiade","year":"2015","unstructured":"Gheorghiade M, Greene SJ, Butler J, Filippatos G, Lam CS, Maggioni AP, et al. Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-REDUCED randomized trial. JAMA. 2015;314(21):2251\u201362. https:\/\/doi.org\/10.1001\/jama.2015.15734.","journal-title":"JAMA"},{"issue":"15","key":"4747_CR19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","volume":"38","author":"B Pieske","year":"2017","unstructured":"Pieske B, Maggioni AP, Lam CSP, Pieske-Kraigher E, Filippatos G, Butler J, et al. Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study. Eur Heart J. 2017;38(15):1119\u201327. https:\/\/doi.org\/10.1093\/eurheartj\/ehw593.","journal-title":"Eur Heart J"},{"key":"4747_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106303","volume":"182","author":"C Sardu","year":"2022","unstructured":"Sardu C, Massetti M, Scisciola L, Trotta MC, Santamaria M, Volpicelli M, et al. Angiotensin receptor\/neprilysin inhibitor effects in CRTd non-responders: from epigenetic to clinical beside. Pharmacol Res. 2022;182:106303. https:\/\/doi.org\/10.1016\/j.phrs.2022.106303.","journal-title":"Pharmacol Res"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04747-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04747-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04747-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:23:24Z","timestamp":1775647404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04747-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4747"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04747-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the ethics committees of all participating institutions (no. 1203). Written informed consent to participate in the study was obtained from all patients prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and approved the final version of the manuscript and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}